RT Journal Article
SR Electronic
T1 Site-specific cancer incidence by race and immigration status in Canada 2006-2015: a population-based data linkage study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.09.22281329
DO 10.1101/2022.11.09.22281329
A1 Malagón, Talía
A1 Morais, Samantha
A1 Tope, Parker
A1 El-Zein, Mariam
A1 Franco, Eduardo L
YR 2022
UL http://medrxiv.org/content/early/2022/11/11/2022.11.09.22281329.abstract
AB Introduction The Canadian Cancer Registry does not collect demographic data beyond age and sex, making it hard to monitor health inequalities in cancer incidence in Canada, a country with public healthcare and many immigrants. Using data linkage, we compared site-specific cancer incidence rates by race.Methods We used data from the 2006 and 2011 Canadian Census Health and Environment Cohorts (CanCHECs), which are population-based probabilistically linked datasets of 5.9 million respondents of the 2006 Canadian long-form census and 6.5 million respondents of the 2011 National Household Survey. Respondents’ race was self-reported using Indigenous identity and visible minority group identity questions. Respondent data were linked with the Canadian Cancer Registry up to 2015. We calculated age-standardized incidence rate ratios (ASIRR), comparing group-specific rates to the overall population rate with bootstrapped 95% confidence intervals (95%CI). We used negative binomial regressions to adjust rates for socioeconomic variables and assess interactions with immigration status.Results The age-standardized cancer incidence rate was lower in almost all non-White racial groups than in White individuals, except for Indigenous peoples who had a similar overall age-standardized cancer incidence rate (ASIRR 0.99, 95%CI 0.97-1.01). Immigrants had substantially lower age-standardized overall cancer incidence rates than non-immigrants (ASIRR 0.83, 95%CI 0.82-0.84). Non-White racial groups generally had significantly lower or equivalent site-specific cancer incidence rates than the overall population, except for stomach, liver, and thyroid cancers and for multiple myeloma. Differences in incidence rates by race persisted even after adjusting for household income, education, and rural residence, with immigration status being an important modifier of cancer risk.Conclusions Differences in cancer incidence between racial groups are likely influenced by differences in lifestyles and early life exposures, as well as selection factors for immigration. This suggests a strong role of environment in determining cancer risk and further potential for cancer prevention.Competing Interest StatementTM, SM, and PT have no conflicts of interest to declare. ELF reports grants to his institution from CIHR, the National Institutes of Health, and Merck during the conduct of the study; and personal fees from Merck. MZ and ELF hold a patent related to the discovery "DNA methylation markers for early detection of cervical cancer", registered at the Office of Innovation and Partnerships, McGill University, Montreal, Quebec, Canada.Funding StatementThis study was funded by a Canadian Institutes of Health Research (CIHR) (grant 179901) to EF, and by a CIHR HIV/AIDS and STBBI Research Initiative, sponsored by the CIHR Institute of Infection and Immunity, Postdoctoral Fellowship Award (support to SM; Funding Reference Number: 202110HIV-477526-93701).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of McGill University gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStatistics Canada is the owner and steward of the data used in this report, and access to the data is regulated by the 1985 Statistics Act. To access the data, researchers must become deemed employees of Statistics Canada and sign a research contract. Members of post-secondary institutions such as a faculty, students, or staff may apply for data access to Statistics Canada microdata through the Research Data Centre program using the Microdata Access Portal (https://www.statcan.gc.ca/en/microdata/data-centres/access). Code used for the current analyses is available at the Borealis repository, at https://doi.org/10.5683/SP3/Z8RBON. https://doi.org/10.5683/SP3/Z8RBON https://www.statcan.gc.ca/en/microdata/data-centres/access